These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 16481168)

  • 1. Development of siRNA for therapeutics: efficient synthesis of phosphorothioate RNA utilizing phenylacetyl disulfide (PADS).
    Ravikumar VT; Andrade M; Carty RL; Dan A; Barone S
    Bioorg Med Chem Lett; 2006 May; 16(9):2513-7. PubMed ID: 16481168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An alternative advantageous protocol for efficient synthesis of phosphorothioate oligonucleotides utilizing phenylacetyl disulfide (PADS).
    Kumar RK; Olsen P; Ravikumar VT
    Nucleosides Nucleotides Nucleic Acids; 2007; 26(2):181-8. PubMed ID: 17365796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solid phase synthesis of phosphorothioate oligonucleotides utilizing diethyldithiocarbonate disulfide (DDD) as an efficient sulfur transfer reagent.
    Cheruvallath ZS; Kumar RK; Rentel C; Cole DL; Ravikumar VT
    Nucleosides Nucleotides Nucleic Acids; 2003 Apr; 22(4):461-8. PubMed ID: 12885126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphorothioate anti-sense oligonucleotides: the kinetics and mechanism of the generation of the sulfurising agent from phenylacetyl disulfide (PADS).
    Scotson JL; Andrews BI; Laws AP; Page MI
    Org Biomol Chem; 2016 Sep; 14(35):8301-8. PubMed ID: 27531007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Versatile and Convenient Synthesis of
    Stulz R; Meuller J; Baždarević D; Wennberg Huldt C; Strömberg R; Andersson S; Dahlén A
    Chembiochem; 2018 Oct; 19(19):2114-2119. PubMed ID: 30062829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphorothioate anti-sense oligonucleotides: the kinetics and mechanism of the sulfurisation of phosphites by phenylacetyl disulfide (PADS).
    Scotson JL; Andrews BI; Laws AP; Page MI
    Org Biomol Chem; 2016 Nov; 14(46):10840-10847. PubMed ID: 27805225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sugar boost: when ribose modifications improve oligonucleotide performance.
    Faria M; Ulrich H
    Curr Opin Mol Ther; 2008 Apr; 10(2):168-75. PubMed ID: 18386229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulfurization of dinucleoside phosphite triesters with chiral disulfides.
    Mukhlall JA; Hersh WH
    Nucleosides Nucleotides Nucleic Acids; 2011 Sep; 30(9):706-25. PubMed ID: 21902473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new approach to stereospecific synthesis of P-chiral phosphorothioates. Preparation of diastereomeric dithymidyl-(3'-5') phosphorothioates.
    Almer H; Szabo T; Stawinski J
    Chem Commun (Camb); 2004 Feb; (3):290-1. PubMed ID: 14740042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Technology evaluation: fomivirsen, Isis Pharmaceuticals Inc/CIBA vision.
    Orr RM
    Curr Opin Mol Ther; 2001 Jun; 3(3):288-94. PubMed ID: 11497353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereocontrolled phosphorothioate synthesis using chiral phosphite triesters.
    Mizuguchi M; Yomogida Y; Makino K
    Nucleic Acids Symp Ser; 1995; (34):113-4. PubMed ID: 8841578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel universal linker for efficient synthesis of phosphorothioate oligonucleotides.
    Wang Z; Olsen P; Ravikumar VT
    Nucleosides Nucleotides Nucleic Acids; 2007; 26(3):259-69. PubMed ID: 17454735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oligonucleotide charge reversal: 2'-O-lysylaminohexyl modified oligonucleotides.
    Winkler J; Noe CR
    Nucleosides Nucleotides Nucleic Acids; 2007; 26(8-9):939-42. PubMed ID: 18058513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Off-target effects related to the phosphorothioate modification of nucleic acids.
    Winkler J; Stessl M; Amartey J; Noe CR
    ChemMedChem; 2010 Aug; 5(8):1344-52. PubMed ID: 20544786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incorporation of 3'-S-phosphorothiolates into RNA: potential applications in RNAi.
    Gaynor J; Fisher J; Campbell B; Cosstick R
    Nucleic Acids Symp Ser (Oxf); 2008; (52):319-20. PubMed ID: 18776382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleic acid therapeutics for hematologic malignancies--theoretical considerations.
    Opalinska JB; Kalota A; Chattopadhyaya J; Damha M; Gewirtz AM
    Ann N Y Acad Sci; 2006 Oct; 1082():124-36. PubMed ID: 17145934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of diastereomeric ratios of deoxyribonucleoside phosphoramidites on the synthesis of phosphorothioate oligonucleotides.
    Cheruvallath ZS; Sasmor H; Cole DL; Ravikumar VT
    Nucleosides Nucleotides Nucleic Acids; 2000 Mar; 19(3):533-43. PubMed ID: 10843490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antisense strategy--new trends].
    Koziołkiewicz M
    Postepy Biochem; 1998; 44(2):125-35. PubMed ID: 9770236
    [No Abstract]   [Full Text] [Related]  

  • 19. Progress in antisense therapeutics discovery and development.
    Crooke ST
    Ciba Found Symp; 1997; 209():158-64; discussion 164-8. PubMed ID: 9383575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereocontrolled synthesis of oligonucleoside phosphorothioates and PO/PS-chimeric oligonucleotides by using oxazaphospholidine derivatives.
    Oka N; Yamamoto M; Sato T; Wada T
    Nucleic Acids Symp Ser (Oxf); 2008; (52):335-6. PubMed ID: 18776390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.